If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
51.00    1.00 (2.00%)
Bid:
50.00
Ask:
52.00
Spread: 2.00 (4.00%)
Market Cap: £97.85m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

IOSorb Patent Awarded

2 Aug 2013 08:30

RNS Number : 8247K
Iofina PLC
02 August 2013
 



2 August 2013

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

 

IOSorb Patent Awarded

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to report that the Company has been awarded a US patent with regards to its IOsorb™ iodine extraction technology.

The new patent was awarded for Iofina's technology, already in use at IO#1 and IO#2, that provides removal of iodine from brine streams that contain hydrocarbon contaminates and are located at the injection site of the operator. These are key components of Iofina's technology as all the Company's sources of iodine are from hydrocarbon contaminated brine streams which are co-produced waste streams associated with shale oil and gas production based at the producer's injection site.

Conventional methods of extracting iodine are typically intolerant of high temperatures and rendered ineffective by hydrocarbon fouling. The conventional iodine extraction systems also are immobile and not modular or mobile like Iofina's WET® IOsorb™ units. This therefore makes conventional iodine extraction systems ill-suited for deployment which is also included in this patent. The issued patent was originally filed in the United States and has been also filed in Chile and Japan shortly thereafter.

Commenting, Chris Fay, Executive Chairman, said: "The IOsorb™ technology is the only technology known which is oil field proven for large scale commercial production of iodine. This patent is a key component in protecting Iofina's IOsorb™ technology utilised in the emerging shale boom in North America.

"We are delighted we have been issued the patent and will continue to finalise the Company's additional patents and trademarks relating to the Company's IOsorb™ technology to ensure a robust intellectual property (IP) portfolio for the Company."

 

 

For further information, please contact:

 

Dr. Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)20 3006 3135

www.iofina.com

 

Ben Colegrave/Chris Sim/James Rudd

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUUBROOAWRRR
Date   Source Headline
13th Jan 20157:00 amRNSTrading Update
22nd Dec 20147:00 amRNSMarket update
16th Dec 20147:00 amRNSBoard Change
8th Dec 20147:00 amRNSExercise of Options and Total Voting Rights
28th Nov 20144:35 pmRNSPrice Monitoring Extension
17th Nov 20147:00 amRNSIssue of Patent and Market Update
30th Oct 20147:00 amRNSExercise of Options and Total Voting Rights
15th Oct 20147:00 amRNSTotal Voting Rights
10th Oct 20142:56 pmRNSTR-1: Notification of Major Interest in Shares
8th Oct 20149:15 amRNSTR-1: Notification of Major Interest in Shares
6th Oct 20147:00 amRNSProduction & Water Permit Update
30th Sep 20147:00 amRNSInterim Results
18th Sep 20147:00 amRNSProduction Update
5th Sep 20147:00 amRNSAppointment of CEO
14th Aug 20147:00 amRNSJuly Production Update
9th Jul 20147:00 amRNSJune Production Update
18th Jun 20147:00 amRNSExercise of Options and Total Voting Rights
10th Jun 20143:42 pmRNSResult of AGM & Appointment of Directors
3rd Jun 20147:00 amRNSIodine Production Update
16th May 20141:58 pmRNSNotice of AGM
6th May 20147:01 amRNSApril Iodine Production Update
29th Apr 20147:00 amRNSSuccessful Completion of Convertible Bond
28th Apr 20147:00 amRNSBoard Changes
25th Apr 20147:00 amRNSFinal Results
23rd Apr 20147:00 amRNSProduction Update
22nd Apr 20147:01 amRNSWater Project Update
15th Apr 20144:40 pmRNSAppointment of Director (amended)
14th Apr 20147:00 amRNSProduction Update
10th Apr 20148:03 amRNSAppointment of Director
7th Apr 20147:00 amRNSHolding(s) in Company
2nd Apr 20144:39 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSMarket update
20th Mar 20147:00 amRNSResignation and appointment of Director
7th Mar 20147:00 amRNSAmendment to the terms of Convertible Bond
28th Feb 20147:01 amRNSIO#4 and IO#5 Update
3rd Feb 20147:00 amRNSNon-Core Water Project Update
29th Jan 20147:00 amRNSOperational Update
28th Jan 20147:00 amRNSHolding(s) in Company
13th Jan 20147:00 amRNSChange of Adviser
6th Jan 201410:12 amRNSDirector Transfer of Shares
23rd Dec 20137:00 amRNSWater Project Update
17th Dec 20133:35 pmRNSDirector Dealing
17th Dec 201310:27 amRNSDirector Dealing
17th Dec 20137:00 amRNS2013 Review and 2014 Outlook
13th Dec 20132:55 pmRNSWater Permit
29th Nov 20137:00 amRNSDirectors' Disclosure
22nd Nov 20137:00 amRNSBoard Change
20th Nov 20137:00 amRNSOperational Update
12th Nov 20137:01 amRNSGrant of Options to Directors
5th Nov 20131:45 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.